Literature DB >> 18365791

[Spanish adaptation of the Scale to Asses Unawareness of Mental Disorder (SUMD)].

A Ruiz1, E Pousa, R Duñó, J Crosas, S Cuppa, C García.   

Abstract

INTRODUCTION: The aim of this paper is to examine the reliability and external validity of the Spanish adaptation of the Scale to Assess Unawareness of Mental Disorder (SUMD).
METHOD: A translation-backtranslation of the original scale was elaborated, and a panel of professionals participated to assess conceptual equivalence and naturality. The scale consists of 3 general items: awareness of mental disorder, awareness of the effects of medication and awareness of the social consequences of the disorder; and of 17 items related to specific symptoms, which make up two subscales: awareness and attribution. Thirty-two patients diagnosed of schizophrenic or schizoaffective disorder following DSM-IV criteria were evaluated. The evaluations were performed using interviews with an observer. Intraclass Correlation Coefficient (ICC) was calculated for the reliability analysis and the Spearman correlation coefficient between the SUMD scores and one independent score of global insight for external validity.
RESULTS: The ICC were all over 0.70. Convergent validity with the independent global measurement of insight was found for the general items of awareness of mental disorder and awareness of the effects of medication, and for the subscale on awareness of symptoms. The awareness of the social consequences of the disorder and the subscale on attribution did not correlate significantly with the global measurement of awareness (insight). These results are consistent with the hypothesis that awareness (insight) is a multidimensional phenomenon.
CONCLUSION: The Spanish adaptation of the SUMD scale is conceptually equivalent and displays a similar reliability and external validity as the original version.

Entities:  

Mesh:

Year:  2008        PMID: 18365791

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  14 in total

1.  Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial.

Authors:  Itxaso González-Ortega; Enrique Echeburúa; Susana Alberich; Miguel Bernardo; Eduard Vieta; Gonzalo Salazar de Pablo; Ana González-Pinto
Journal:  Int J Environ Res Public Health       Date:  2022-06-15       Impact factor: 4.614

Review 2.  Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness of Mental Disorder (SUMD).

Authors:  Rémy Dumas; Karine Baumstarck; Pierre Michel; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Curr Psychiatry Rep       Date:  2013-06       Impact factor: 5.285

3.  Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial.

Authors:  Sara Barbeito; Patricia Vega; Sonia Ruiz de Azua; Vicent Balanza-Martinez; Francesc Colom; Esther Lorente; Ana Luengo; Ester Cerrillo; José Manuel Crespo; Ana González Pinto
Journal:  Trials       Date:  2014-10-27       Impact factor: 2.279

4.  Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia.

Authors:  Auria Albacete; Fernando Contreras; Clara Bosque; Ester Gilabert; Ángela Albiach; José M Menchón; Benedicto Crespo-Facorro; Rosa Ayesa-Arriola
Journal:  Front Psychol       Date:  2016-05-09

5.  Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.

Authors:  Itxaso González-Ortega; Enrique Echeburúa; Adriana García-Alocén; Patricia Vega; Ana González-Pinto
Journal:  Trials       Date:  2016-07-29       Impact factor: 2.279

6.  The right occipital lobe and poor insight in first-episode psychosis.

Authors:  Diana Tordesillas-Gutierrez; Rosa Ayesa-Arriola; Manuel Delgado-Alvarado; Jennifer L Robinson; Javier Lopez-Morinigo; Jesus Pujol; M Encarnación Dominguez-Ballesteros; Anthony S David; Benedicto Crespo-Facorro
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

7.  Adherence to Antipsychotic Medication and Quality of Life in Latin-American Patients Diagnosed with Schizophrenia.

Authors:  Alejandra Caqueo-Urízar; Alfonso Urzúa; Patricio Mena-Chamorro; Guillaume Fond; Laurent Boyer
Journal:  Patient Prefer Adherence       Date:  2020-09-03       Impact factor: 2.711

8.  Delusional Disorder over the Reproductive Life Span: The Potential Influence of Menopause on the Clinical Course.

Authors:  Alexandre González-Rodríguez; Oriol Molina-Andreu; Rafael Penadés; Marina Garriga; Alexandre Pons; Rosa Catalán; Miguel Bernardo
Journal:  Schizophr Res Treatment       Date:  2015-10-27

9.  Insight and illness perception in Mexican patients with psychosis.

Authors:  Lizzette Gómez-de-Regil
Journal:  Schizophr Res Cogn       Date:  2015-03-05

10.  Family Features of Social Withdrawal Syndrome (Hikikomori).

Authors:  Ángeles Malagón-Amor; Luis Miguel Martín-López; David Córcoles; Anna González; Magda Bellsolà; Alan R Teo; Antoni Bulbena; Víctor Pérez; Daniel Bergé
Journal:  Front Psychiatry       Date:  2020-03-02       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.